<dl><dt>1</dt><dd id="tr1"><p>{{'LOAD_TRANSACTION'|translate}}</p><ul><li>A file should not be loaded if it is the first REP transaction for this dossier.</li><li>When continuing with a working copy, the format of the file to load should be .hcsc.</li><li>When viewing/updating a final XML file, the format of the file to load should be .xml.</li></ul><p class="fn-rtn"><a href="#tr1_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>1 <span class="wb-inv">referrer</span></a></p></dd><dt>1a</dt><dd id="tr1a"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::'RESET'|translate}}</p><p>To enable the "generate final XML" button, select the "reset" button to clear transaction specific fields.</p><p class="fn-rtn"><a href="#tr1a_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>1.a <span class="wb-inv">referrer</span></a></p></dd><dt>1b</dt><dd id="tr1b"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::"IS_ADMIN_SUBMISSION" |translate}}</p><div class="ng-scope"><p>Refer to the <a target="_blank" href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/guidance-administrative-processing-human-disinfectant-drugs.html">Guidance Administrative Processing of Submissions and Applications: Human or Disinfectant Drugs</a></p></div><p class="fn-rtn"><a href="#tr1b_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>1.b <span class="wb-inv">referrer</span></a></p></dd><dt>1c</dt><dd id="tr1c"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::"CONTROL_NUM" |translate}}</p><ul><li>Enter the 6 digit control number associated with this regulatory activity (if known).</li><li>Enter “000000” for regulatory transactions that Do Not require a control number (e.g. Level III - Post-NOC Changes, UDRA – DIN cancellations, UDRA - Notification Interruption of sale, UDRA - eCTD Dossier Clean-up).</li><li>Enter “000000” for the first transaction of a NEW regulatory activity, where a control number has not yet been assigned.</li><li>Enter the pre-assigned control number for the first transaction of a new regulatory activity that was communicated by Health Canada (e.g. via an Advisement Letter).</li></ul><p class="fn-rtn"><a href="#tr1c_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>1.c <span class="wb-inv">referrer</span></a></p></dd><dd id="tr1d"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}}{{::'REGULATORY_FEES' |translate}}</p><p>For more information related to fees, refer to the <a target="_blank" href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications.html">Guidance Document - Fees for the Review of Drug Submissions and Applications</a></p><p class="fn-rtn"><a href="#tr1d_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>1.d <span class="wb-inv">referrer</span></a></p></dd><dt>2</dt><dd id="tr2"><p>{{::'DOSSIER_TYPE'|translate}}</p><ul><li>Biologic dossier applies to all biologic products and radiopharmaceuticals</li><li>Pharmaceutical dossier applies to all pharmaceutical products, non-prescription products, disinfectants</li></ul><p class="fn-rtn"><a href="#tr2_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>2 <span class="wb-inv">referrer</span></a></p></dd><dt>3</dt><dd id="tr3"><P>{{::"COMPANY_ID" |translate}}</P><p>The “Company ID” must be obtained from the final company XML file, issued by Health Canada.</p><p class="fn-rtn"><a href="#tr3_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>3 <span class="wb-inv">referrer</span></a></p></dd><dt>4</dt><dd id="tr4"><P>{{::"DOSSIER_ID" |translate}}</P><p>The “Dossier ID” can be obtained from the final dossier XML file or other Health Canada issued document if the dossier ID was assigned prior to REP. The format of a Dossier ID is a letter followed by six digits. (e.g. HC6-024-x######).</p><p class="fn-rtn"><a href="#tr4_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>4 <span class="wb-inv">referrer</span></a></p></dd><dt>5</dt><dd id="tr5"><p>{{::"PROD_NAME" |translate}}</p><p>The product name (also known as the brand name or proprietary name) is the name assigned by the manufacturer or sponsor to the dossier (product), and under which the product is to be sold and advertised. The product name is also the name used to identify the product in all submission correspondence, Product Label(s) and Product Monograph/Package Insert, if applicable. If the product name has not yet been determined, the following may be used: “TBD” (short for To Be Determined), the proper or common name of the drug, or the research code.</p><p class="fn-rtn"><a href="#tr5_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>5 <span class="wb-inv">referrer</span></a></p></dd><dt>5a</dt><dd id="5a"><p>{{'SECTION_IS_NOT_VISIBLE'|translate}} {{::'FAX_NUMBER'|translate}}</p><p>Use 0000000000 if not available</p><p class="fn-rtn"><a href="#5a_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>5.a <span class="wb-inv">referrer</span></a></p></dd><dt>6</dt><dd id="tr6"><p>{{::'REG_CONTACT_THIS' |translate}}</p><ul><li>Information provided here pertains to <b>the contact specific to the subject regulatory activity,</b> i.e., the person/company to whom Health Canada should direct correspondence about the subject regulatory activity.</li><li>Please note that it is up to the discretion of Health Canada to decide the method of correspondence.</li><li>If you are adding a record to previously submitted final regulatory transaction xml, these fields will be prepopulated with the information of the previous transaction (sequence number).</li><li>Sponsors should update this information if required; otherwise confirm that the information is still valid.</li><li>Enter the name of the company to which the regulatory activity contact belongs. If the contact does not belong to a company, enter the name of the contact.</li></ul><p class="fn-rtn"><a href="#tr6_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>6 <span class="wb-inv">referrer</span></a></p></dd><dt>7</dt><dd id="tr7"><p>{{::"COMPANY_NOABBREV" |translate}}</p><p>If the company differs from the sponsor, a letter of authorization signed by the manufacturer/sponsor must be provided in section 1.2.6 of the regulatory transaction.</p><p class="fn-rtn"><a href="#tr7_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>7 <span class="wb-inv">referrer</span></a></p></dd><dt>8</dt><dd id="tr8"><p>{{::'GENERATE_FINAL'|translate}}</p><ul><li>A final regulatory transaction XML file must be included in section 1.2.1 for each of your REP transactions.</li><li>Refer to the REP guidance document for detailed information.</li></ul><p class="fn-rtn"><a href="#tr8_ref"><span class="wb-inv">{{::'RETURN_INSTRUCTION'|translate}}</span>8 <span class="wb-inv">referrer</span></a></p></dd></dl>